DE60121953D1 - Herstellungsverfahren von arzneizubereitungen - Google Patents

Herstellungsverfahren von arzneizubereitungen

Info

Publication number
DE60121953D1
DE60121953D1 DE60121953T DE60121953T DE60121953D1 DE 60121953 D1 DE60121953 D1 DE 60121953D1 DE 60121953 T DE60121953 T DE 60121953T DE 60121953 T DE60121953 T DE 60121953T DE 60121953 D1 DE60121953 D1 DE 60121953D1
Authority
DE
Germany
Prior art keywords
medicine preparations
manufacturing medicine
manufacturing
preparations
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121953T
Other languages
English (en)
Other versions
DE60121953T2 (de
Inventor
Patrick Busson
Marco Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121953(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60121953D1 publication Critical patent/DE60121953D1/de
Application granted granted Critical
Publication of DE60121953T2 publication Critical patent/DE60121953T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60121953T 2000-06-27 2001-06-18 Herstellungsverfahren von arzneizubereitungen Expired - Lifetime DE60121953T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27
EP00113535 2000-06-27
PCT/EP2001/006834 WO2002000201A2 (en) 2000-06-27 2001-06-18 Method for preparing a composition

Publications (2)

Publication Number Publication Date
DE60121953D1 true DE60121953D1 (de) 2006-09-14
DE60121953T2 DE60121953T2 (de) 2007-03-08

Family

ID=8169074

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121953T Expired - Lifetime DE60121953T2 (de) 2000-06-27 2001-06-18 Herstellungsverfahren von arzneizubereitungen

Country Status (38)

Country Link
US (3) US6534087B2 (de)
EP (1) EP1296656B1 (de)
JP (2) JP4149803B2 (de)
KR (1) KR100557845B1 (de)
CN (1) CN1236764C (de)
AR (1) AR029278A1 (de)
AT (1) ATE334662T1 (de)
AU (2) AU2001281846B2 (de)
BR (1) BRPI0112014B1 (de)
CA (1) CA2411153C (de)
CY (1) CY1105714T1 (de)
CZ (1) CZ301813B6 (de)
DE (1) DE60121953T2 (de)
DK (1) DK1296656T3 (de)
EC (1) ECSP024401A (de)
EG (1) EG24141A (de)
ES (1) ES2269441T3 (de)
HK (1) HK1058314A1 (de)
HR (1) HRP20021009B1 (de)
HU (1) HU229550B1 (de)
IL (2) IL153282A0 (de)
JO (1) JO2247B1 (de)
MA (1) MA26922A1 (de)
ME (1) ME00672B (de)
MX (1) MXPA02012583A (de)
MY (1) MY129798A (de)
NO (1) NO332181B1 (de)
NZ (1) NZ523024A (de)
PE (1) PE20020101A1 (de)
PL (1) PL203804B1 (de)
PT (1) PT1296656E (de)
RU (1) RU2244542C2 (de)
SI (1) SI1296656T1 (de)
TW (1) TWI278325B (de)
UY (1) UY26799A1 (de)
WO (1) WO2002000201A2 (de)
YU (1) YU96602A (de)
ZA (1) ZA200209649B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
SI1296656T1 (sl) * 2000-06-27 2006-12-31 Hoffmann La Roche Postopek priprave sestavka
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
CN1325050C (zh) * 2002-04-26 2007-07-11 霍夫曼-拉罗奇有限公司 包含脂肪酶抑制剂和葡甘露聚糖的药物组合物
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
WO2005055921A2 (en) 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
CA2562213A1 (en) * 2004-04-06 2005-11-24 Rpg Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
EP1790966A1 (de) * 2004-09-15 2007-05-30 Banyu Pharmaceutical Co., Ltd. Probenahmeverfahren und vorrichtung sowie logd-messverfahren und -messsytem
EP2163196A3 (de) * 2004-12-31 2010-11-03 Mikhail Yurievich Gotovsky Apparat zur Bestimmung des Vorhandenseins von Fremdsubstanzen in einem lebenden Organismus und zur individuellen Auswahl von Zusammensetzungen zur Erhöhung der Lebensenergie in einem Organismus
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
US20060246141A1 (en) * 2005-04-12 2006-11-02 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
WO2006138431A2 (en) * 2005-06-16 2006-12-28 Eastman Chemical Company Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
EP1951186A4 (de) 2005-10-19 2009-11-04 Menni Menashe Zinger Verfahren zur behandlung von hyperhydrose
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
JP2009530614A (ja) 2006-03-16 2009-08-27 デューク ユニバーシティ フーリエ領域光コヒーレンス・トモグラフィーに基づく実時間直角位相投影を実行するための方法、システム及びコンピュータプログラム製品
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (de) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmazeutische Zusammensetzung enthaltend Tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
NZ582049A (en) * 2007-05-18 2012-12-21 Tti Ellebeau Inc Transdermal delivery devices assuring an improved release of an active principle through a biological interface
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
EP2219614A1 (de) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmazeutische zusammensetzung von orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
MX2011012586A (es) 2009-05-26 2012-03-26 Advanced Bionutrition Corp Composicion de polvo seco estable que comprende microorganismos biologicamente activos y/o materiales bioactivos y metodos de elaboracion.
EP2482802A4 (de) * 2009-09-29 2013-08-07 Michael Burnet Neuartige pestizidformulierungen
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
RU2535869C2 (ru) 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
WO2011126030A1 (ja) * 2010-04-07 2011-10-13 三菱瓦斯化学株式会社 保存安定性に優れたｓ－アデノシル－ｌ－メチオニン含有乾燥酵母組成物及びその製造方法
CN103140145B (zh) 2010-08-13 2014-08-20 高级生物营养公司 用于生物材料的干的贮存稳定用组合物
JP2013540827A (ja) 2010-10-29 2013-11-07 ウエスタン ユニバーシティ オブ ヘルス サイエンシズ 三種混合製剤
MX341035B (es) 2011-03-01 2016-08-03 Procter & Gamble Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal.
CA2866889C (en) 2012-03-23 2021-08-31 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
EP3314007B1 (de) 2015-06-25 2024-01-24 Native Microbials, Inc. Verfahren, vorrichtungen und systeme zur analyse von mikroorganismenstämmen aus komplexen heterogenen gemeinschaften, zur vorhersage und identifizierung funktionaler beziehung davon und auswahl und synthetisierung mikrobieller ensembles auf basis davon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
AU2016297986B8 (en) 2015-07-29 2020-06-11 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
US11891647B2 (en) 2016-12-28 2024-02-06 Native Microbials, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
JP3722294B2 (ja) * 1993-02-23 2005-11-30 ワーナー−ランバート・コンパニー 実質的にアルコールを含有しない医薬組成物の製造方法
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
CN101172957B (zh) 1995-02-27 2012-11-14 吉里德科学公司 新颖化合物,其合成方法及治疗用途
HU228450B1 (en) 1995-02-27 2013-03-28 Gilead Sciences Inc Novel selective inhibitors of viral or bacterial neuraminidases
NZ309841A (en) * 1995-06-07 1999-10-28 Quadrant Holdings Cambridge Methods for producing foamed glass matrices (fgm) and compositions obtained thereby
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ES2217410T3 (es) * 1996-04-16 2004-11-01 Novartis Consumer Health S.A. Forma de dosificacion oral de rapida desintegracion.
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
EP1097705A2 (de) * 1996-10-14 2001-05-09 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines pulverförmigen Präparates
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
DK1071402T3 (da) * 1998-04-09 2007-02-19 Hoffmann La Roche Fremgangsmåde til af partikler med (sub)mikronstörrelse ved oplösning i komprimeret gas og overfladeaktive stoffer
WO2000009122A1 (en) 1998-08-14 2000-02-24 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors
TR200100472T2 (tr) * 1998-08-14 2001-07-23 F.Hoffmann-La Roche Ag Lipaz inhibitörleri ile sitozan içeren farmasötik bileşimler
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
ES2307482T3 (es) 1999-02-10 2008-12-01 Pfizer Products Inc. Dispersiones farmaceuticas solidas.
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
SI1296656T1 (sl) * 2000-06-27 2006-12-31 Hoffmann La Roche Postopek priprave sestavka

Also Published As

Publication number Publication date
RU2244542C2 (ru) 2005-01-20
NO20026197D0 (no) 2002-12-23
US20060134205A1 (en) 2006-06-22
ECSP024401A (es) 2003-02-06
BRPI0112014B1 (pt) 2016-09-13
UY26799A1 (es) 2001-12-28
ATE334662T1 (de) 2006-08-15
AR029278A1 (es) 2003-06-18
PT1296656E (pt) 2006-12-29
ES2269441T3 (es) 2007-04-01
WO2002000201A3 (en) 2002-04-18
YU96602A (sh) 2005-03-15
CZ301813B6 (cs) 2010-06-30
JP2007302683A (ja) 2007-11-22
MY129798A (en) 2007-04-30
MEP90608A (en) 2011-12-20
EP1296656B1 (de) 2006-08-02
CZ2003212A3 (cs) 2003-06-18
HK1058314A1 (en) 2004-05-14
NZ523024A (en) 2004-08-27
AU8184601A (en) 2002-01-08
CN1236764C (zh) 2006-01-18
PE20020101A1 (es) 2002-02-12
ZA200209649B (en) 2004-03-10
HRP20021009B1 (en) 2011-07-31
NO332181B1 (no) 2012-07-16
BR0112014A (pt) 2003-05-13
WO2002000201A2 (en) 2002-01-03
KR20030023880A (ko) 2003-03-20
CA2411153C (en) 2007-01-30
US6534087B2 (en) 2003-03-18
HUP0302060A2 (hu) 2003-09-29
IL153282A0 (en) 2003-07-06
DE60121953T2 (de) 2007-03-08
JP2004501184A (ja) 2004-01-15
US20030039614A1 (en) 2003-02-27
HUP0302060A3 (en) 2006-07-28
HRP20021009A2 (en) 2004-02-29
ME00672B (me) 2011-12-20
CA2411153A1 (en) 2002-01-03
CY1105714T1 (el) 2010-12-22
PL365803A1 (en) 2005-01-10
DK1296656T3 (da) 2006-11-27
CN1438880A (zh) 2003-08-27
US7074431B2 (en) 2006-07-11
NO20026197L (no) 2002-12-23
KR100557845B1 (ko) 2006-03-10
MA26922A1 (fr) 2004-12-20
MXPA02012583A (es) 2003-04-10
JO2247B1 (en) 2004-10-07
EG24141A (en) 2008-08-06
IL153282A (en) 2008-03-20
PL203804B1 (pl) 2009-11-30
SI1296656T1 (sl) 2006-12-31
TWI278325B (en) 2007-04-11
US20020018812A1 (en) 2002-02-14
HU229550B1 (en) 2014-01-28
EP1296656A2 (de) 2003-04-02
AU2001281846B2 (en) 2006-04-27
JP4149803B2 (ja) 2008-09-17

Similar Documents

Publication Publication Date Title
DE60121953D1 (de) Herstellungsverfahren von arzneizubereitungen
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
NO20033556D0 (no) Farmasöytiske preparater
NO20071303L (no) Farmasoytiske preparater
FR14C0080I2 (fr) Methode d'administration d'un anticorps
NO20035426D0 (no) Fremgangsmåte ved administrering av anti-TNF-D-antistoff
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
ATE411332T1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE50104789D1 (de) Desodorierende Zubereitungen
NO20040353L (no) Ny terapeutsk metode
ID30187A (id) Dongkrak jenis pantagraf
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60126814D1 (de) Inhalation von stickoxid
NO20044916L (no) Preparater av sulfinylacetamid
ATE355062T1 (de) Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung
DE50003755D1 (de) Satz von schmuckstücken
DE60132362D1 (de) Herstellung von ultradünnwandigen cordierit-strukturen
DE60232290D1 (de) Kontrollierte Auflösung von Wirkstoffen
DE60142051D1 (de) Herstellung von perfluorolefinen
FI20000194A0 (fi) Menetelmä kaupankäynnissä
DE60103685D1 (de) Behandlung von Poriomania
EE200200653A (et) alfa-2,4-disulfofenüül-N-tert-butüülnitrooni uuedpreparaadid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition